Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy.

Kubisch R, Meissner L, Krebs S, Blum H, Günther M, Roidl A, Wagner E.

Transl Oncol. 2013 Feb;6(1):1-9. Epub 2013 Feb 1.

PMID:
23418611
[PubMed]
Free PMC Article
2.

In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy.

Thoenes L, Hoehn M, Kashirin R, Ogris M, Arnold GJ, Wagner E, Guenther M.

J Proteomics. 2010 May 7;73(7):1342-54. doi: 10.1016/j.jprot.2010.02.019. Epub 2010 Feb 25.

PMID:
20219715
[PubMed - indexed for MEDLINE]
3.

Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.

Wang R, Qin S, Chen Y, Li Y, Chen C, Wang Z, Zheng R, Wu Q.

Oncol Rep. 2012 Aug;28(2):439-45. doi: 10.3892/or.2012.1828. Epub 2012 May 22.

PMID:
22641525
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors.

Olsson A, Björk A, Vallon-Christersson J, Isaacs JT, Leanderson T.

Mol Cancer. 2010 May 17;9:107. doi: 10.1186/1476-4598-9-107.

PMID:
20470445
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Identification of docetaxel resistance genes in castration-resistant prostate cancer.

Marín-Aguilera M, Codony-Servat J, Kalko SG, Fernández PL, Bermudo R, Buxo E, Ribal MJ, Gascón P, Mellado B.

Mol Cancer Ther. 2012 Feb;11(2):329-39. doi: 10.1158/1535-7163.MCT-11-0289. Epub 2011 Oct 25.

PMID:
22027694
[PubMed - indexed for MEDLINE]
Free Article
7.

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells.

Linn DE, Yang X, Sun F, Xie Y, Chen H, Jiang R, Chen H, Chumsri S, Burger AM, Qiu Y.

Genes Cancer. 2010 Sep;1(9):908-16. doi: 10.1177/1947601910388271.

PMID:
21779471
[PubMed]
Free PMC Article
9.

Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts.

Kullmann F, Judex M, Ballhorn W, Jüsten HP, Wessinghage D, Welsh J, Yen TJ, Lang B, Hittle JC, McClelland M, Gay S, Schölmerich J, Müller-Ladner U.

Arthritis Res. 1999;1(1):71-80. Epub 1999 Oct 26.

PMID:
11056662
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.

Nadiminty N, Dutt S, Tepper C, Gao AC.

Prostate. 2010 Feb 15;70(3):276-87. doi: 10.1002/pros.21062.

PMID:
19827050
[PubMed - indexed for MEDLINE]
11.

VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment.

Patten SG, Adamcic U, Lacombe K, Minhas K, Skowronski K, Coomber BL.

BMC Cancer. 2010 Dec 15;10:683. doi: 10.1186/1471-2407-10-683.

PMID:
21159176
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.

Bindukumar B, Schwartz SA, Nair MP, Aalinkeel R, Kawinski E, Chadha KC.

Neoplasia. 2005 Mar;7(3):241-52. Erratum in: Neoplasia. 2005 May;7(5):544.

PMID:
15799824
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.

Hoffmann J, Sommer A.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):191-200. Epub 2005 Jan 28.

PMID:
15860262
[PubMed - indexed for MEDLINE]
14.

Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.

Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE.

Cancer Res. 2002 Sep 15;62(18):5325-35.

PMID:
12235003
[PubMed - indexed for MEDLINE]
Free Article
15.

Gene expression profiling: identification of genes with altered expression in Ayu17-449 knockout mice.

Li Y, Huang TT, Tang H, Yamamura KI, Pu XY.

Genet Mol Res. 2011;10(3):1533-44.

PMID:
21863549
[PubMed - indexed for MEDLINE]
Free Article
16.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
[PubMed - indexed for MEDLINE]
17.

Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line.

Khalyfa A, Chlon T, Qiang H, Agarwal N, Cooper NG.

Mol Vis. 2007 Feb 28;13:293-308.

PMID:
17356516
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID:
16854453
[PubMed - indexed for MEDLINE]
20.

The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells.

Lin JC, Chang SY, Hsieh DS, Lee CF, Yu DS.

Oncol Rep. 2005 May;13(5):983-8.

PMID:
15809768
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk